A study in the Journal of the American Medical Association compared the safety outcomes from nearly 50 trials of eight blood-thinning regimens. Apixaban use for three months was associated with a 0.28% chance of major bleeding, the lowest rate among the treatments studied. Rivaroxaban was associated with a 0.49% risk, compared to risks of about 0.89% for the other treatments.
D.C. Chartered Health Plan is trying out a wellness program for enrollees with diabetes that includes sending text messages with advice for living with diabetes, reminders to schedule eye and foot examinations, tips for adhering to medication regimens, interactive quizzes, and announcements for community events. The Medicaid managed care provider will expand the program if it is successful.
The expanding mobile-device market will help both providers and patients, says Robert Oscar, CEO of Web analytics and technology company RxEOB. Oscar sees the potential for improved care through better compliance with prescription drug regimens, better tracking and communication of discharge instructions, increased access to health data and the creation of aggregated data on outcomes and public health trends.
Merck will invest $8.5 million initially and an additional $8.5 million in milestone payments in Physicians Interactive, for development of digital marketing tools, online platforms for drug sample sales, data analytics and mobile health products.
The NIH's free, online program, titled Genetics and Social Science: Expanding Transdisciplinary Research, is intended to bring together geneticists and behavioral and social scientists in interdisciplinary research. Core areas are variation and gene-environment interaction, as well as population, research and clinical issues, according to an NIH announcement.